| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10930493 | Cytotherapy | 2015 | 7 Pages |
Abstract
The process for CD34 selection with Prodigy is robust and labor-saving but not time-saving. Compared with clinical CD34+ selected products concurrently generated with the predecessor technology, product properties, importantly including CD34+ cell recovery and T-cell contents, were not significantly different. The automatic system is suitable for routine clinical application.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Gabriele Spohn, Eliza Wiercinska, Darja Karpova, Milica Bunos, Christiane Hümmer, Eva Wingenfeld, Nadine Sorg, Carolin Poppe, Volker Huppert, Juliane Stuth, Kristina Reck, Mike Essl, Erhard Seifried, Halvard Bönig,